Importance of citrate and the calcium: Citrate ratio in patients with calcium renal lithiasis and severe lithogenesis

BJU International

Volumn 111, Issue 4, 2013, Pages 622-627

  Arrabal Polo, Miguel Angel ^a   Arrabal Martin, Miguel ^a   Arias Santiago, Salvador ^b,c   Garrido Gomez, Juan ^a   Poyatos Andujar, Antonio ^a   Zuluaga Gomez, Armando ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b Baza Hospital   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

Author keywords

bone; lithogenic activity; urinary calcium: citrate ratio; urinary citrate

Indexed keywords

CALCIUM; CALCIUM OXALATE; CITRIC ACID; OSTEOCALCIN; PARATHYROID HORMONE;

ADULT; ARTICLE; BONE DENSITOMETRY; BONE DENSITY; CALCIUM URINE LEVEL; CHRONIC DISEASE; CITRIC ACID URINE LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMUR NECK; HIP; HUMAN; HYPOCITRATURIA; LUMBAR SPINE; MAJOR CLINICAL STUDY; NEPHROLITHIASIS; OSTEOLYSIS; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SPAIN; STONE FORMATION; URINE LEVEL;

ADULT; BIOLOGICAL MARKERS; BONE DENSITY; CALCIUM; CALCULI; CITRIC ACID; CONFIDENCE INTERVALS; CREATININE; CROSS-SECTIONAL STUDIES; DECALCIFICATION, PATHOLOGIC; FEMALE; HUMANS; INCIDENCE; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEPHROLITHIASIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; ROC CURVE; SEVERITY OF ILLNESS INDEX; SPAIN; URINALYSIS;

EID: 84875832730     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11292.x     Document Type: Article

References (22)

1. Arrabal Martin M, Fernandez Rodriguez A, Arrabal Polo MA, Ruiz Garcia MJ, Zuluaga Gomez A., Study of the physical-chemical factors in patients with renal lithiasis. Arch Esp Urol 2006; 59: 583-594
2. Amaro CR, Goldberg J, Amaro JL, Padovani CR,. Metabolic assessment in patients with urinary lithiasis. Int Braz J Urol 2005; 31: 29-33
3. Netelenbos JC, Zwijnenburg PJ, ter Wee PM., Risk factors determining active urinary stone formation in patients with urolithiasis. Clin Nephrol 2005; 63: 188-192
4. Karabacak OR, Ipek B, Ozturk U, Demirel F, Saltas H, Altug U,. Metabolic evaluation in stone disease metabolic differences between the pediatric and adult patients with stone disease. Urology 2010; 76: 238-241
5. Tekin A, Tekgul S, Atsu N, Sahin A, Ozen H, Bakkaloglu M,. A study of the etiology of idiopathic calcium urolithiasis in children: hypocitraturia is the most important risk factor. J Urol 2000; 164: 162-165
6. Simic-Ogrizovic S, Dopsaj V, Jovicic S, Milenkovic D, Jovanovic D, Nesic V., The most important factor for active urinary stone formation in patients with urolithiasis. Med Pregl 2007; 60: 117-120
7. Chandhoke PS., Evaluation of the recurrent stone former. Urol Clin North Am 2007; 34: 315-322
8. Arrabal-Polo MA, Arrabal-Martin M, de, Haro-Munoz T, et al. Mineral density and bone remodelling markers in patients with calcium lithiasis. BJU Int 2011; 108: 1903-1908
9. Park S, Pearle MS,. Pathophysiology and management of calcium stones. Urol Clin North Am 2007; 34: 323-334
10. Hosseini MM, Eshraghian A, Dehghanian I, Irani D, Amini M,. Metabolic abnormalities in patients with nephrolithiasis: comparison of first-episode with recurrent cases in Southern Iran. Int Urol Nephrol 2010; 42: 127-131
11. Mithani S, Zaidi Z,. Comparison of 24 hours urinary citrate levels in urolithiasis patients and healthy controls. J Pak Med Assoc 2005; 55: 371-373
12. DeFoor WR, Jackson E, Minevich E, et al. The risk of recurrent urolithiasis in children is dependent on urinary calcium and citrate. Urology 2010; 76: 242-246
13. Batista Peres LA, Sella Langer S, Schmidt RC, et al. Nephrolithiasis in pediatric patients: metabolic and anatomical investigation. J Bras Nefrol 2011; 33: 34-38
14. Hofbauer J, Höbarth K, Zechner O,. The significance of citrate excretion and calcium/citrate quotients in urine in patients with calcium calculi. Z Urol Nephrol 1990; 83: 597-602
15. Höbarth K, Hofbauer J,. Value of routine citrate analysis and calcium/citrate ration in calcium urolithiasis. Eur Urol 1991; 19: 165-168
16. Pak CYC, Peterson RD, Poindexter J,. Prevention of spinal bone loss by potassium citrate in cases of calcium urolithiasis. J Urol 2002; 168: 31-34
17. Caudarella R, Vescini F, Buffa A, Stefoni S,. Citrate and mineral metabolism: kidney stones and bone disease. Front Biosci 2003; 8: s1084-1086
18. Giannini S, Nobile N, Sartori L, et al. Bone density and skeletal metabolism are altered in idiopathic hypercalciuria. Clin Nephrol 1998; 50: 94-100
19. Caudarella R, Vescini F, Buffa A, et al. Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors. J Nephrol 2003; 16: 260-266
20. Audran M, Bataille P, Sebert JL, et al. Bone density in idiopathic hypercalciuria in men. Study by dual photon absorptiometry, X-ray computed tomography and histomorphometry. Rev Rhum Mal Osteoartic 1991; 58: 747-750
21. Zanchetta JR, Rodriguez G, Negri AL, del Valle E, Spivacow FR., Bone mineral density in patients with hypercalciuric nephrolithiasis. Nephron 1996; 73: 557-560
22. Jaeger P, Lippuner K, Casez JP, Hess B, Ackermann D, Hug C,. Low bone mass in idiopathic renal stone formers: magnitude and significance. J Bone Miner Res 1994; 9: 1525-1532